Literature DB >> 17656099

Abnormal processing of tau in the brain of aged TgCRND8 mice.

Arianna Bellucci1, Maria Cristina Rosi, Cristina Grossi, Anna Fiorentini, Ilaria Luccarini, Fiorella Casamenti.   

Abstract

Amyloid plaques and neurofibrillary tangles are the main histopathological hallmarks of Alzheimer's disease (AD). In the neocortex and hippocampus of aged TgCRND8 mice, tau is hyperphosphorylated at different sites recognized by PHF-1, AT100, AT8 and CP13 antibodies. Phospho-SAPK/JNK levels were increased in the tg mouse brain, where activated SAPK/JNK co-localizes with PHF-1-positive cells. Phosphorylated tau-positive cells showed Bielschowsky- and Thioflavine S-positive intraneuronal deposits. PHF-1 and nitrotyrosine immunoreactivity merged within neurons surrounding amyloid deposits in cortical and hippocampal areas and immunoprecipitation studies confirmed that tau is nitrosylated. Our findings, demonstrating the presence of hyperphosphorylated and nitrosylated tau protein as well as of insoluble aggregates after the onset of amyloid deposition in the TgCRND8 mouse brain, indicate that the abnormal processing of tau may occur subsequently to cerebral amyloidosis and that activation of SAPK/JNK and induction of nitrosative stress are the more likely connecting factors between amyloidosis and tauopathy in AD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17656099     DOI: 10.1016/j.nbd.2007.06.008

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  17 in total

1.  Object recognition memory and BDNF expression are reduced in young TgCRND8 mice.

Authors:  Beverly M Francis; John Kim; Meredith E Barakat; Stephan Fraenkl; Yeni H Yücel; Shiyong Peng; Bernadeta Michalski; Margaret Fahnestock; Joanne McLaurin; Howard T J Mount
Journal:  Neurobiol Aging       Date:  2010-05-05       Impact factor: 4.673

2.  The γ-secretase modulator CHF5074 reduces the accumulation of native hyperphosphorylated tau in a transgenic mouse model of Alzheimer's disease.

Authors:  Annamaria Lanzillotta; Ilenia Sarnico; Marina Benarese; Caterina Branca; Cristina Baiguera; Birgit Hutter-Paier; Manfred Windisch; Pierfranco Spano; Bruno Pietro Imbimbo; Marina Pizzi
Journal:  J Mol Neurosci       Date:  2010-12-22       Impact factor: 3.444

Review 3.  Role of ganglioside metabolism in the pathogenesis of Alzheimer's disease--a review.

Authors:  Toshio Ariga; Michael P McDonald; Robert K Yu
Journal:  J Lipid Res       Date:  2008-03-11       Impact factor: 5.922

4.  Nonlinear dynamical analysis of carbachol induced hippocampal oscillations in mice.

Authors:  Metin Akay; Kui Wang; Yasemin M Akay; Andrei Dragomir; Jie Wu
Journal:  Acta Pharmacol Sin       Date:  2009-06       Impact factor: 6.150

Review 5.  Role of RAGE in Alzheimer's Disease.

Authors:  Zhiyou Cai; Nannuan Liu; Chuanling Wang; Biyong Qin; Yingjun Zhou; Ming Xiao; Liying Chang; Liang-Jun Yan; Bin Zhao
Journal:  Cell Mol Neurobiol       Date:  2015-07-15       Impact factor: 5.046

6.  CB₂ receptor deficiency increases amyloid pathology and alters tau processing in a transgenic mouse model of Alzheimer's disease.

Authors:  Jeremy Koppel; Valerie Vingtdeux; Philippe Marambaud; Cristina d'Abramo; Heidy Jimenez; Mark Stauber; Rachel Friedman; Peter Davies
Journal:  Mol Med       Date:  2013-11-08       Impact factor: 6.354

7.  c-Jun N-terminal kinase regulates soluble Aβ oligomers and cognitive impairment in AD mouse model.

Authors:  Alessandra Sclip; Xanthi Antoniou; Alessio Colombo; Giovanni G Camici; Laura Pozzi; Daniele Cardinetti; Marco Feligioni; Pietro Veglianese; Ferdinand H Bahlmann; Luigi Cervo; Claudia Balducci; Cinzia Costa; Alessandro Tozzi; Paolo Calabresi; Gianluigi Forloni; Tiziana Borsello
Journal:  J Biol Chem       Date:  2011-10-27       Impact factor: 5.157

8.  Sexually Dimorphic Expression of Reelin in the Brain of a Mouse Model of Alzheimer Disease.

Authors:  Giampiero Palladino; Vincenzina Nicolia; Gabor G Kovacs; Sonia Canterini; Viviana Ciraci; Andrea Fuso; Franco Mangia; Sigfrido Scarpa; Maria Teresa Fiorenza
Journal:  J Mol Neurosci       Date:  2016-11-19       Impact factor: 3.444

9.  Caspase activation in transgenic mice with Alzheimer-like pathology: results from a pilot study utilizing the caspase inhibitor, Q-VD-OPh.

Authors:  Troy T Rohn; Polina Kokoulina; Cody R Eaton; Wayne W Poon
Journal:  Int J Clin Exp Med       Date:  2009-11-05

10.  CB2 receptor deficiency increases amyloid pathology and alters tau processing in a transgenic mouse model of Alzheimer's disease.

Authors:  Jeremy Koppel; Valerie Vingtdeux; Philippe Marambaud; Cristina d'Abramo; Heidy Jimenez; Mark Stauber; Rachel Friedman; Peter Davies
Journal:  Mol Med       Date:  2014-03-14       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.